USD 0.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 4.93 Million USD | 331.62% |
2018 | 1.14 Million USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 Q3 | 1.5 Million USD | 19.89% |
2020 Q2 | 1.25 Million USD | -7.77% |
2020 FY | - USD | -100.0% |
2020 Q1 | 1.36 Million USD | 74.21% |
2019 FY | 4.93 Million USD | 331.62% |
2019 Q4 | 781.47 Thousand USD | -41.04% |
2019 Q3 | 1.32 Million USD | -1.18% |
2019 Q2 | 1.34 Million USD | -9.7% |
2019 Q1 | 1.48 Million USD | 102.49% |
2018 Q4 | 733.58 Thousand USD | 187.62% |
2018 Q2 | 153.07 Thousand USD | 11032.58% |
2018 Q1 | 1375.00 USD | 0.0% |
2018 FY | 1.14 Million USD | 0.0% |
2018 Q3 | 255.05 Thousand USD | 66.62% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | -17.06 Thousand USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 100.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | -13.83 Thousand USD | 6.09% |
2016 Q4 | - USD | 100.0% |
2016 Q2 | -14.73 Thousand USD | 13.82% |
2016 Q1 | -17.09 Thousand USD | 0.0% |
2015 Q3 | -13.9 Thousand USD | -0.48% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 100.0% |
2015 Q2 | -13.84 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 100.0% |
2014 Q1 | -16.73 Thousand USD | 0.0% |
2014 Q3 | -13.83 Thousand USD | 4.93% |
2014 Q2 | -14.54 Thousand USD | 13.08% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 100.0% |
2013 Q2 | -13.65 Thousand USD | 22.96% |
2013 Q1 | -17.72 Thousand USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 Q3 | -15.53 Thousand USD | -36.55% |
2012 Q4 | - USD | 100.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | -11.37 Thousand USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q2 | -12.7 Thousand USD | 0.0% |
2011 Q3 | -12.42 Thousand USD | 2.27% |
2011 Q4 | - USD | 100.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 100.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | -12.45 Thousand USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Bright Green Corporation | -237.01 Thousand USD | 100.0% |
BioQuest Corp. | - USD | NaN% |
Clever Leaves Holdings Inc. | 6.55 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 5.39 Million USD | 100.0% |
High Sierra Technologies, Inc. | -56.39 Thousand USD | 100.0% |
Instadose Pharma Corp. | - USD | NaN% |